Data / Form D filings / SYNDEVRX INC
SYNDEVRX INC: Form D filings
SYNDEVRX INC, a biotechnology company in Cambridge, MA, filed 24 Form D notices with the SEC between 2009 and 2025. The latest, on December 23, 2025, reports $6.5 million sold of a $20 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE BROADWAY, 14TH FLOOR, Cambridge, MA, 02142
- Phone
- (617) 401-3110
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1455364
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Amendment | $20,000,000 | $6,467,100 | $13,532,900 | 7 | Nov 4, 2024 | sec.gov |
| Nov 17, 2025 | Amendment | $12,000,000 | $6,467,100 | $5,532,900 | 7 | Nov 4, 2024 | sec.gov |
| Nov 15, 2024 | New notice | $12,000,000 | $978,000 | $11,022,000 | 5 | Nov 4, 2024 | sec.gov |
| Oct 10, 2024 | New notice | $29,354,820 | $29,354,820 | 13 | Sep 30, 2024 | sec.gov | |
| Dec 20, 2023 | Amendment | $30,000,000 | $23,249,350 | $6,750,650 | 7 | Jan 9, 2020 | sec.gov |
| Dec 14, 2022 | Amendment | $30,000,000 | $18,444,727 | $11,555,273 | 6 | Jan 9, 2020 | sec.gov |
| Dec 30, 2021 | Amendment | $25,000,000 | $14,672,214 | $10,327,786 | 7 | Jan 9, 2020 | sec.gov |
| Jan 15, 2021 | Amendment | $15,000,000 | $9,197,000 | $5,803,000 | 7 | Jan 9, 2020 | sec.gov |
| Jan 17, 2020 | New notice | $12,000,000 | $6,100,000 | $5,900,000 | 6 | Jan 9, 2020 | sec.gov |
| Mar 19, 2019 | Amendment | $5,000,000 | $850,000 | $4,150,000 | 4 | Mar 12, 2018 | sec.gov |
| Mar 21, 2018 | New notice | $5,000,000 | $500,000 | $4,500,000 | 1 | Mar 12, 2018 | sec.gov |
| Nov 9, 2017 | Amendment | $2,500,000 | $1,500,000 | $1,000,000 | 1 | Aug 1, 2017 | sec.gov |
| Aug 15, 2017 | New notice | $2,000,000 | $500,000 | $1,500,000 | 1 | Aug 1, 2017 | sec.gov |
| Mar 20, 2017 | Amendment | $18,000,000 | $16,285,471 | $1,714,529 | 40 | Oct 25, 2012 | sec.gov |
| Jul 13, 2016 | Amendment | $15,000,000 | $13,410,221 | $1,589,779 | 38 | Oct 25, 2012 | sec.gov |
| Apr 28, 2016 | Amendment | $15,000,000 | $12,410,221 | $2,589,779 | 38 | Oct 25, 2012 | sec.gov |
| Sep 15, 2015 | Amendment | $15,000,000 | $11,306,646 | $3,693,354 | 38 | Oct 25, 2012 | sec.gov |
| Dec 20, 2013 | Amendment | $11,000,000 | $2,212,747 | $8,787,253 | 27 | Oct 25, 2012 | sec.gov |
| May 31, 2013 | Amendment | $4,500,000 | $1,610,000 | $2,890,000 | 8 | Oct 25, 2012 | sec.gov |
| Nov 8, 2012 | New notice | $150,000 | $15,000 | $135,000 | 2 | Oct 25, 2012 | sec.gov |
| Jul 27, 2010 | Amendment | $2,000,000 | $225,000 | $1,775,000 | 10 | May 10, 2010 | sec.gov |
| Jul 20, 2010 | Amendment | $1,570,000 | $1,294,659 | $275,341 | 11 | Jul 14, 2009 | sec.gov |
| May 24, 2010 | New notice | $1,000,000 | $80,000 | $920,000 | 7 | May 7, 2010 | sec.gov |
| Jul 23, 2009 | New notice | $1,570,000 | $569,659 | $1,000,341 | 11 | Jul 14, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bradley J Carver | Executive Officer, Director | |
| David Michael Neafus | Executive Officer | |
| Charles Michael Flynn | Director | |
| Jeffrey Michael Welles | Director | |
| James Michael Shanahan | Executive Officer, Director | |
| Michael Michael Clifford | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 22, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SYNDEVRX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.